Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis
暂无分享,去创建一个
Mithat Gonen | Christopher E. Mason | Omar Abdel-Wahab | Ross L. Levine | Sylvie Provost | Cameron Brennan | Adriana Heguy | C. Mason | C. Brennan | N. Socci | A. Viale | M. Gonen | O. Abdel-Wahab | A. Heguy | A. Melnick | M. Figueroa | R. Levine | L. Busque | L. Godley | Jay P. Patel | A. Vasanthakumar | Aparna Vasanthakumar | Agnes Viale | Ari Melnick | S. Provost | Lambert Busque | Lucy A. Godley | Zineb Hamilou | L. Mollica | Juan Li | Maryam Hassimi | P. Bhatt | Maryam Hassimi | Luigina Mollica | Maria Figueroa | Zineb Hamilou | Juan Li | Nicholas Socci | Parva K. Bhatt | Z. Hamilou | Nicholas B Socci | Ari Melnick | Omar Abdel-Wahab | Ross Levine | Lucy A. Godley | Lambert Busque | Jay P. Patel | Maria Figueroa | Sylvie Provost | Zineb Hamilou | Juan Li | Agnes Viale | Adriana Heguy | Maryam Hassimi | Parva K. Bhatt | Mithat Gonen | Christopher E. Mason | Cameron Brennan
[1] J. Licht,et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.
[2] D. Gilliland,et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. , 1996, Blood.
[3] O. Abdel-Wahab,et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.
[4] J. Soulier,et al. Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.
[5] P. Opolon,et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.
[6] C. Harrison,et al. Acquired skewing of X‐chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age , 1997, British journal of haematology.
[7] L. Aravind,et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 , 2010, Nature.
[8] Feng-Chun Yang,et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. , 2011, Blood.
[9] I. Weissman,et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion , 2010, Proceedings of the National Academy of Sciences.
[10] D. Gilliland,et al. X-inactivation analysis in the 1990s: promise and potential problems , 1998, Leukemia.
[11] K. Rajewsky,et al. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice , 2011, Proceedings of the National Academy of Sciences.
[12] D. Gilliland,et al. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis , 2009, Leukemia.
[13] W. Maloney,et al. Stem cells and the aging hematopoietic system. , 2010, Current opinion in immunology.